Last 716.90 INR
Change Today +2.40 / 0.34%
Volume 651.1K
GNP On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arpad Szallasi M.D., Ph.D., FCAP

Member of the Scientific Advisory Board, Glenmark Pharmaceuticals Ltd.
AgeTotal Calculated CompensationThis person is connected to 17 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Dr. Arpad Szallasi is Hematopathologist and Medical Director for the Transfusion Services, Monmouth Medical Center Long Branch, NJ. Dr. Szallasi serves as Adjunct Professor of Pathology and Laboratory Medicine, Drexel University College of Medicine, Philadelphia and PA Medical Advisor to the American Red Cross Advisor to a number of drug discovery companies worldwide. Dr. Szallasi serves as Member of Scientific Board at PharmEste s.r.l Dr. Szallasi serves as Member of ...

Read Full Background

Corporate Headquarters*

Glenmark House
Mumbai, Maharashtra 400099

India

Phone: 91 22 4018 9999
Fax: 91 22 4018 9990

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNP:IN 716.90 INR +2.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Arun Sawhney B.Com., P.G.D.B.M.Managing Director, Chief Executive Officer, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee, Member of Science Committee, Member of Quality & Integrity Committee and Member of Corporate Social Responsibility Committee
Ranbaxy Laboratories Ltd.
122.7M
Arthur S. Przybyl Chief Executive Officer, President and Director
ANI Pharmaceuticals, Inc.
$400.5K
Arthur P. Bedrosian J.D.Chief Executive Officer, President, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$437.5K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLENMARK PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.